-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
All investors
114 institutional investors
Content Filter
-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
-
Hankang Capital
- Investments: 75
- Funds: 13
- Shanghai
-
Photovoltaic
-
Grid/power transmission
-
Digital technology for carbon accounting and consulting
Hankang Capital (formerly "Shanghai Jianxin Capital") is a venture capital focusing on the biomedical industry. We pay attention to major diseases and major clinical needs, carry out in-depth research, support pioneering companies with first-class team and technology platform in advance, and provide professional insights, experience and resources in product pipeline, team building, application and registration, clinical trials, etc. to promote them to become leading enterprises in the industry as soon as possible. We have invested in Innocare Pharma Limited, Akeso, Chip Screen, Keymed Biosciences, AbbiskoTherapeutics and other industry leading companies. Hankang Capital has won the honors such as "TOP 100 Venture Capital Institutions", "TOP 20 Healthcare Investment Institutions", and "TOP 50 Venture Capital Institutions Recognized by LP in China" for many times.
-
Future Capital
- Investments: 234
- Funds: 6
- Jiaxing, Zhejiang Province
-
Energy storage
-
Electric vehicles
-
Green transportation
-
Other renewable energy (nuclear, geothermal, etc.)
Future Capital was established in 2014, mainly investing in private technology companies in seed stage, early stage and early growth stage. The company mainly focuses on the technology department of enterprises and selectively invest in revolutionary consumer technologies. Future Capital is one of the first venture capital funds specializing in the technology industry of Chinese enterprises, with a capital management scale of 1 billion US dollars. Future Capital has invested in more than 170 enterprises, and its main investment fields cover corporate software/services, AI/big data, intelligent mobile, cutting-edge technology, intelligent logistics, intelligent manufacturing, intelligent supply chain and consumption upgrading.